MARIA JESUS
SANZ FERRANDO
CATEDRÀTIC/A D'UNIVERSITAT
SERGIO
MARTINEZ HERVAS
TITULAR DE UNIVERSIDAD
Publications by the researcher in collaboration with SERGIO MARTINEZ HERVAS (13)
2022
-
Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity
Microvascular Research, Vol. 139
-
Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
Biomedicine and Pharmacotherapy, Vol. 145
-
Effect of personality on blood glucose control in patients with type 1 diabetes
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 677-685
2021
-
Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients
Frontiers in Pharmacology, Vol. 12
-
Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes
International Journal of Clinical Practice, Vol. 75, Núm. 8
-
Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects
International Journal of Clinical Practice, Vol. 75, Núm. 4
2019
-
Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus
Translational Research, Vol. 203, pp. 31-48
-
Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation
Journal of Clinical Medicine, Vol. 8, Núm. 1
-
Systemic inflammation in metabolic syndrome: Increased platelet and leukocyte activation, and key role of CX3 CL1/CX3 CR1 and CCL2/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion
Journal of Clinical Medicine, Vol. 8, Núm. 5
2018
-
Functional role of endothelial CXCL16/ CXCR6-platelet–leucocyte axis in angiotensin II-associated metabolic disorders
Cardiovascular Research, Vol. 114, Núm. 13, pp. 1764-1775
2016
-
Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway
Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393
2015
-
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis
Journal of Endocrinology, Vol. 227, Núm. 3, pp. 179-191
2014
-
Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis
Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336